Predicting Response to Treatment in Systemic Sclerosis-Related Interstitial Lung Disease in a Multicenter Observational Cohort and CONQUER
CONQUER Registry to Track Disease Progression in Systemic Sclerosis (Scleroderma)
Sponsor: Scleroderma Research Foundation
Enrolling: Male and Female Patients
IRB Number: AAAR6143
Contact: Elana Bernstein, MD: 212-305-4308 /
Additional Study Information: The purpose of this study is to develop a cohort of patients with early scleroderma and to collect data on clinical outcomes, radiological tests, laboratory tests, and to obtain biological specimens for testing.
Elana Bernstein, MD
Do You Qualify?
Are you at least 18 years old? Yes No
Have you been diagnosed with systemic sclerosis (scleroderma)? Yes No
You may be eligible for this study

Place Holder

For more information, please contact:
Elana Bernstein, MD